Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Bonavida

Showing results (81-90 of 192) with videos related to

Pageof 20
Sort By:
Redox Biology|August 31, 2015
Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapyValentina Rapozzi, Emilia Della Pietra, Benjamin Bonavida
Cancer Biotherapy & Radiopharmaceuticals|January 23, 2003
Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbineChristos Emmanouilides, Ali R Jazirehi, Benjamin Bonavida
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphomaSteve Alas, Chuen-Pei Ng, Benjamin Bonavida
Cancers|October 14, 2022
The Role of RKIP in the Regulation of EMT in the Tumor MicroenvironmentHannah Cessna, Stavroula Baritaki, Apostolos Zaravinos, et al.
Cancer Research|February 7, 2007
Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapyAli R Jazirehi, Mario I Vega, Benjamin Bonavida
Cancers|December 24, 2021
RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in ImmunityRoni Touboul, Stavroula Baritaki, Apostolos Zaravinos, et al.
Cancer Drug Resistance (Alhambra, Calif.)|March 21, 2022
Cell-mediated immune resistance in cancerYuhao Wang, Emily Hays, Martina Rama, et al.
Cancers|January 11, 2025
The Role of YY1 in the Regulation of LAG-3 Expression in CD8 T Cells and Immune Evasion in Cancer: Therapeutic ImplicationsAdam Merenstein, Loiy Obeidat, Apostolos Zaravinos, et al.
Cancers|August 29, 2018
RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and ImpactApostolos Zaravinos, Benjamin Bonavida, Ekaterini Chatzaki, et al.
International Journal of Oncology|January 16, 2003
Immunosensitization of resistant human tumor cells to cytotoxicity by tumor infiltrating lymphocytesPatrick Frost, Randy Caliliw, Arie Belldegrun, et al.
Pageof 20

Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
Redox Biology|August 31, 2015
Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapyValentina Rapozzi, Emilia Della Pietra, Benjamin Bonavida
Cancer Biotherapy & Radiopharmaceuticals|January 23, 2003
Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbineChristos Emmanouilides, Ali R Jazirehi, Benjamin Bonavida
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphomaSteve Alas, Chuen-Pei Ng, Benjamin Bonavida
Cancers|October 14, 2022
The Role of RKIP in the Regulation of EMT in the Tumor MicroenvironmentHannah Cessna, Stavroula Baritaki, Apostolos Zaravinos, et al.
Cancer Research|February 7, 2007
Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapyAli R Jazirehi, Mario I Vega, Benjamin Bonavida
Cancers|December 24, 2021
RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in ImmunityRoni Touboul, Stavroula Baritaki, Apostolos Zaravinos, et al.
Cancer Drug Resistance (Alhambra, Calif.)|March 21, 2022
Cell-mediated immune resistance in cancerYuhao Wang, Emily Hays, Martina Rama, et al.
Cancers|January 11, 2025
The Role of YY1 in the Regulation of LAG-3 Expression in CD8 T Cells and Immune Evasion in Cancer: Therapeutic ImplicationsAdam Merenstein, Loiy Obeidat, Apostolos Zaravinos, et al.
Cancers|August 29, 2018
RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and ImpactApostolos Zaravinos, Benjamin Bonavida, Ekaterini Chatzaki, et al.
International Journal of Oncology|January 16, 2003
Immunosensitization of resistant human tumor cells to cytotoxicity by tumor infiltrating lymphocytesPatrick Frost, Randy Caliliw, Arie Belldegrun, et al.
Pageof 20